{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T05:53:23Z","timestamp":1777269203137,"version":"3.51.4"},"reference-count":123,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:p>Although organ transplantation is a life-saving medical procedure, the challenge of posttransplant rejection necessitates safe and effective immune modulation strategies. Nanodelivery approaches may have the potential to overcome the limitations of small-molecule immunosuppressive drugs, achieving efficacious treatment options for transplant tolerance without compromising overall host immunity. This review highlights recent advances in biomaterial-assisted formulations and technologies for targeted nanodrug delivery with transplant organ- or immune cell\u2013level precision for treating graft rejection after transplantation. We provide an overview of the mechanism of transplantation rejection, current clinically approved immunosuppressive drugs, and their relevant limitations. Finally, we discuss the targeting principles and advantages of organ- and immune cell\u2013specific delivery technologies. The development of biomaterial-assisted novel therapeutic strategies holds considerable promise for treating organ rejection and clinical translation.<\/jats:p>","DOI":"10.1097\/tp.0000000000005025","type":"journal-article","created":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T15:00:46Z","timestamp":1712761246000},"page":"2174-2185","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Nanoparticle-assisted Targeting Delivery Technologies for Preventing Organ Rejection"],"prefix":"10.1097","volume":"108","author":[{"given":"Fanchao","family":"Meng","sequence":"first","affiliation":[{"name":"Jinan Microecological Biomedicine Shandong Laboratory, Jinan, Shandong Province, People\u2019s Republic of China."},{"name":"The First Affiliated Hospital, NHC Key Laboratory of Combined Multi-Organ Transplantation, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, People\u2019s Republic of China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, People\u2019s Republic of China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyang","family":"Xie","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital, NHC Key Laboratory of Combined Multi-Organ Transplantation, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, People\u2019s Republic of China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hangxiang","family":"Wang","sequence":"additional","affiliation":[{"name":"Jinan Microecological Biomedicine Shandong Laboratory, Jinan, Shandong Province, People\u2019s Republic of China."},{"name":"The First Affiliated Hospital, NHC Key Laboratory of Combined Multi-Organ Transplantation, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, People\u2019s Republic of China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,4,8]]},"reference":[{"key":"R1-20250604","doi-asserted-by":"crossref","first-page":"a014977","DOI":"10.1101\/cshperspect.a014977","article-title":"Historical overview of transplantation.","volume":"3","author":"Barker","year":"2013","journal-title":"Cold Spring Harb Perspect Med"},{"key":"R2-20250604","doi-asserted-by":"crossref","first-page":"409","DOI":"10.21037\/atm.2018.09.68","article-title":"Solid organ transplantation in the 21(st) century.","volume":"6","author":"Black","year":"2018","journal-title":"Ann Transl Med"},{"key":"R3-20250604","first-page":"493","article-title":"Cyclosporine in transplantation\u2014a history of converging timelines.","volume":"25","author":"Colombo","year":"2011","journal-title":"J Biol Regul Homeost Agents"},{"key":"R4-20250604","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1097\/TP.0000000000002700","article-title":"Improved survival in liver transplant patients receiving prolonged-release tacrolimus-based immunosuppression in the European Liver Transplant Registry (ELTR): an extension study.","volume":"103","author":"Adam","year":"2019","journal-title":"Transplantation"},{"key":"R5-20250604","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.hbpd.2019.05.006","article-title":"Hepatocellular carcinoma recurrence after acute liver allograft rejection treatment: a multicenter European experience.","volume":"18","author":"Lai","year":"2019","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"R6-20250604","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/lt.20391","article-title":"Analysis of risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma: key role of immunosuppression.","volume":"11","author":"Vivarelli","year":"2005","journal-title":"Liver Transpl"},{"key":"R7-20250604","doi-asserted-by":"crossref","first-page":"e1302","DOI":"10.1093\/cid\/ciaa1189","article-title":"Immunosuppressive agents and infectious risk in transplantation: managing the \u201cnet state of immunosuppression.\u201d","volume":"73","author":"Roberts","year":"2021","journal-title":"Clin Infect Dis"},{"key":"R8-20250604","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.2215\/CJN.15040920","article-title":"Long-term immunosuppression management: opportunities and uncertainties.","volume":"16","author":"Wojciechowski","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"key":"R9-20250604","first-page":"5","article-title":"Pharmacokinetic principles of immunosuppressive drugs.","volume":"13","author":"Budde","year":"2008","journal-title":"Ann Transplant"},{"key":"R10-20250604","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/1098-2752(2000)20:8<420::AID-MICR13>3.0.CO;2-O","article-title":"Immunosuppressive agents in transplantation: mechanisms of action and current anti-rejection strategies.","volume":"20","author":"Gorantla","year":"2000","journal-title":"Microsurgery"},{"key":"R11-20250604","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nbt.3330","article-title":"Principles of nanoparticle design for overcoming biological barriers to drug delivery.","volume":"33","author":"Blanco","year":"2015","journal-title":"Nat Biotechnol"},{"key":"R12-20250604","doi-asserted-by":"crossref","first-page":"17124","DOI":"10.1021\/acsnano.1c04707","article-title":"Intra-organ delivery of nanotherapeutics for organ transplantation.","volume":"15","author":"Hussain","year":"2021","journal-title":"ACS Nano"},{"key":"R13-20250604","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41565-020-00810-2","article-title":"Inducing immune tolerance with dendritic cell-targeting nanomedicines.","volume":"16","author":"Cifuentes-Rius","year":"2021","journal-title":"Nat Nanotechnol"},{"key":"R14-20250604","doi-asserted-by":"crossref","first-page":"123","DOI":"10.5500\/wjt.v9.i6.123","article-title":"Histopathological characteristics and causes of kidney graft failure in the current era of immunosuppression.","volume":"9","author":"Parajuli","year":"2019","journal-title":"World J Transplant"},{"key":"R15-20250604","doi-asserted-by":"crossref","first-page":"7771","DOI":"10.3748\/wjg.v27.i45.7771","article-title":"Chronic rejection after liver transplantation: opening the Pandora\u2019s box.","volume":"27","author":"Angelico","year":"2021","journal-title":"World J Gastroenterol"},{"issue":"1 Pt 2","key":"R16-20250604","first-page":"2203","article-title":"Chronic liver allograft rejection and obliterative arteriopathy: possible pathogenic mechanisms.","volume":"21","author":"Oguma","year":"1989","journal-title":"Transplant Proc"},{"key":"R17-20250604","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/lt.500050519","article-title":"Evolving concepts in the diagnosis, pathogenesis, and treatment of chronic hepatic allograft rejection.","volume":"5","author":"Wiesner","year":"1999","journal-title":"Liver Transpl Surg"},{"key":"R18-20250604","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1097\/TP.0000000000001215","article-title":"Chronic lung allograft dysfunction: a systematic review of mechanisms.","volume":"100","author":"Royer","year":"2016","journal-title":"Transplantation"},{"key":"R19-20250604","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.21037\/jtd.2017.07.81","article-title":"Chronic lung allograft dysfunction phenotypes and treatment.","volume":"9","author":"Verleden","year":"2017","journal-title":"J Thorac Dis"},{"key":"R20-20250604","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/MOT.0000000000000263","article-title":"Direct and indirect allograft recognition: pathways dictating graft rejection mechanisms.","volume":"21","author":"Lin","year":"2016","journal-title":"Curr Opin Organ Transplant"},{"key":"R21-20250604","doi-asserted-by":"crossref","first-page":"582","DOI":"10.3389\/fimmu.2016.00582","article-title":"Allorecognition by T lymphocytes and allograft rejection.","volume":"7","author":"Marino","year":"2016","journal-title":"Front Immunol"},{"key":"R22-20250604","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1111\/j.1600-6143.2010.03053.x","article-title":"T cell-mediated rejection of kidney transplants: a personal viewpoint.","volume":"10","author":"Halloran","year":"2010","journal-title":"Am J Transplant"},{"key":"R23-20250604","doi-asserted-by":"crossref","first-page":"eadd8454","DOI":"10.1126\/sciimmunol.add8454","article-title":"Tissue-resident memory T cell maintenance during antigen persistence requires both cognate antigen and interleukin-15.","volume":"8","author":"Tieu","year":"2023","journal-title":"Sci Immunol"},{"key":"R24-20250604","doi-asserted-by":"crossref","first-page":"eabk0270","DOI":"10.1126\/sciadv.abk0270","article-title":"Skin and heart allograft rejection solely by long-lived alloreactive T(RM) cells in skin of severe combined immunodeficient mice.","volume":"8","author":"Tian","year":"2022","journal-title":"Sci Adv"},{"key":"R25-20250604","doi-asserted-by":"crossref","first-page":"eabc8122","DOI":"10.1126\/sciimmunol.abc8122","article-title":"Resident memory T cells form during persistent antigen exposure leading to allograft rejection.","volume":"6","author":"Abou-Daya","year":"2021","journal-title":"Sci Immunol"},{"key":"R26-20250604","doi-asserted-by":"crossref","first-page":"5525","DOI":"10.4049\/jimmunol.1501686","article-title":"The complement system and antibody-mediated transplant rejection.","volume":"195","author":"Stites","year":"2015","journal-title":"J Immunol"},{"key":"R27-20250604","doi-asserted-by":"crossref","first-page":"e13208","DOI":"10.1111\/ctr.13208","article-title":"Complement system in lung transplantation.","volume":"32","author":"Ali","year":"2018","journal-title":"Clin Transplant"},{"key":"R28-20250604","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/MOT.0000000000000040","article-title":"Antibody-mediated graft injury: complement-dependent and complement-independent mechanisms.","volume":"19","author":"Valenzuela","year":"2014","journal-title":"Curr Opin Organ Transplant"},{"key":"R29-20250604","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s002620050600","article-title":"The role of monocytes and natural killer cells in mediating antibody-dependent lysis of colorectal tumour cells.","volume":"48","author":"Abdullah","year":"1999","journal-title":"Cancer Immunol Immunother"},{"key":"R30-20250604","first-page":"439","article-title":"Further evidence that antibody-dependent and spontaneous cell-mediated cytotoxicity are mediated by different processes or cell types.","volume":"41","author":"MacDermott","year":"1980","journal-title":"Immunology"},{"key":"R31-20250604","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/0092-8674(94)90115-5","article-title":"FcR gamma chain deletion results in pleiotrophic effector cell defects.","volume":"76","author":"Takai","year":"1994","journal-title":"Cell"},{"key":"R32-20250604","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/TP.0000000000003804","article-title":"Macrophages in transplantation: a matter of plasticity, polarization, and diversity.","volume":"106","author":"Panzer","year":"2022","journal-title":"Transplantation"},{"key":"R33-20250604","doi-asserted-by":"crossref","first-page":"887565","DOI":"10.3389\/fimmu.2022.887565","article-title":"The role of neutrophils as a driver in hepatic ischemia-reperfusion injury and cancer growth.","volume":"13","author":"Kaltenmeier","year":"2022","journal-title":"Front Immunol"},{"key":"R34-20250604","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ebiom.2018.01.025","article-title":"Ischemia-reperfusion injury reduces long term renal graft survival: mechanism and beyond.","volume":"28","author":"Zhao","year":"2018","journal-title":"EBioMed"},{"key":"R35-20250604","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1097\/TP.0000000000004038","article-title":"DAMPs released from injured renal tubular epithelial cells activate innate immune signals in healthy renal tubular epithelial cells.","volume":"106","author":"DeWolf","year":"2022","journal-title":"Transplantation"},{"key":"R36-20250604","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.1111\/ajt.13963","article-title":"Transplantation and damage-associated molecular patterns (DAMPs).","volume":"16","author":"Land","year":"2016","journal-title":"Am J Transplant"},{"key":"R37-20250604","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1517\/14712598.2012.689278","article-title":"Anti-T-cell antibodies for the treatment of acute rejection after renal transplantation.","volume":"12","author":"van den Hoogen","year":"2012","journal-title":"Expert Opin Biol Ther"},{"key":"R38-20250604","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1097\/TXD.0000000000000595","article-title":"Alemtuzumab as antirejection therapy: T cell repopulation and cytokine responsiveness.","volume":"2","author":"Bouvy","year":"2016","journal-title":"Transplant Direct"},{"key":"R39-20250604","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1097\/TP.0000000000003095","article-title":"Recommended treatment for antibody-mediated rejection after kidney transplantation: the 2019 expert consensus from the Transplantation Society Working Group.","volume":"104","author":"Schinstock","year":"2020","journal-title":"Transplantation"},{"key":"R40-20250604","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/MOT.0000000000001011","article-title":"Antibody-mediated rejection: prevention, monitoring and treatment dilemmas.","volume":"27","author":"Rodriguez-Ramirez","year":"2022","journal-title":"Curr Opin Organ Transplant"},{"issue":"Suppl 1","key":"R41-20250604","first-page":"S85","article-title":"The CARI guidelines. Calcineurin inhibitors in renal transplantation: nephrotoxicity and calcineurin inhibitors.","volume":"12","author":"Coates","year":"2007","journal-title":"Nephrology (Carlton)"},{"key":"R42-20250604","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1053\/j.ackd.2019.08.006","article-title":"The many faces of calcineurin inhibitor toxicity\u2014what the FK?","volume":"27","author":"Farouk","year":"2020","journal-title":"Adv Chronic Kidney Dis"},{"key":"R43-20250604","first-page":"106","article-title":"Systemic treatment-induced gastrointestinal toxicity: incidence, clinical presentation and management.","volume":"25","author":"Boussios","year":"2012","journal-title":"Ann Gastroenterol"},{"key":"R44-20250604","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery.","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"R45-20250604","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nnano.2007.387","article-title":"Nanocarriers as an emerging platform for cancer therapy.","volume":"2","author":"Peer","year":"2007","journal-title":"Nat Nanotechnol"},{"key":"R46-20250604","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.addr.2012.09.037","article-title":"Liposomal drug delivery systems: from concept to clinical applications.","volume":"65","author":"Allen","year":"2013","journal-title":"Adv Drug Deliv Rev"},{"key":"R47-20250604","doi-asserted-by":"crossref","first-page":"16982","DOI":"10.1021\/acsnano.1c04996","article-title":"Lipid nanoparticles\u2014from liposomes to mRNA vaccine delivery, a landscape of research diversity and advancement.","volume":"15","author":"Tenchov","year":"2021","journal-title":"ACS Nano"},{"key":"R48-20250604","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/s41551-018-0234-x","article-title":"Micelles with ultralow critical micelle concentration as carriers for drug delivery.","volume":"2","author":"Lu","year":"2018","journal-title":"Nat Biomed Eng"},{"key":"R49-20250604","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.molmed.2021.03.003","article-title":"Lipid nanoparticle-mediated delivery of mRNA therapeutics and vaccines.","volume":"27","author":"Swingle","year":"2021","journal-title":"Trends Mol Med"},{"key":"R50-20250604","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1126\/science.1070821","article-title":"Self-assembly at all scales.","volume":"295","author":"Whitesides","year":"2002","journal-title":"Science"},{"key":"R51-20250604","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1097\/TP.0000000000003060","article-title":"Liposomal delivery improves the efficacy of prednisolone to attenuate renal inflammation in a mouse model of acute renal allograft rejection.","volume":"104","author":"van Alem","year":"2020","journal-title":"Transplantation"},{"key":"R52-20250604","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jconrel.2011.08.009","article-title":"Nano-sized drug-loaded micelles deliver payload to lymph node immune cells and prolong allograft survival.","volume":"156","author":"Dane","year":"2011","journal-title":"J Control Release"},{"key":"R53-20250604","doi-asserted-by":"crossref","first-page":"e159672","DOI":"10.1172\/JCI159672","article-title":"Delivery of costimulatory blockade to lymph nodes promotes transplant acceptance in mice.","volume":"132","author":"Zhao","year":"2022","journal-title":"J Clin Investig"},{"key":"R54-20250604","doi-asserted-by":"crossref","first-page":"10646","DOI":"10.1021\/nn3037573","article-title":"Simultaneous diagnosis and gene therapy of immuno-rejection in rat allogeneic heart transplantation model using a T-cell-targeted theranostic nanosystem.","volume":"6","author":"Guo","year":"2012","journal-title":"ACS Nano"},{"key":"R55-20250604","doi-asserted-by":"crossref","first-page":"eabq3699","DOI":"10.1126\/sciadv.abq3699","article-title":"Nanoparticle delivery of CD40 siRNA suppresses alloimmune responses by inhibiting activation and differentiation of DCs and macrophages.","volume":"8","author":"Wang","year":"2022","journal-title":"Sci Adv"},{"key":"R56-20250604","doi-asserted-by":"crossref","first-page":"e2207227","DOI":"10.1002\/adma.202207227","article-title":"Lymph-node-targeted drug delivery for effective immunomodulation to prolong the long-term survival after heart transplantation.","volume":"35","author":"Che","year":"2023","journal-title":"Adv Mater"},{"key":"R57-20250604","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1097\/TP.0000000000004207","article-title":"Novel complement C5 small-interfering RNA lipid nanoparticle prolongs graft survival in a hypersensitized rat kidney transplant model.","volume":"106","author":"Ishigooka","year":"2022","journal-title":"Transplantation"},{"key":"R58-20250604","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1166\/jbn.2019.2777","article-title":"Albumin based nanomedicine for enhancing tacrolimus safety and lymphatic targeting efficiency.","volume":"15","author":"Zhang","year":"2019","journal-title":"J Biomed Nanotechnol"},{"key":"R59-20250604","doi-asserted-by":"crossref","first-page":"4770","DOI":"10.1172\/JCI120923","article-title":"Targeted delivery of immune therapeutics to lymph nodes prolongs cardiac allograft survival.","volume":"128","author":"Bahmani","year":"2018","journal-title":"J Clin Investig"},{"key":"R60-20250604","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1111\/ajt.16748","article-title":"Targeting peripheral immune organs with self-assembling prodrug nanoparticles ameliorates allogeneic heart transplant rejection.","volume":"21","author":"Zhou","year":"2021","journal-title":"Am J Transplant"},{"key":"R61-20250604","doi-asserted-by":"crossref","first-page":"12393","DOI":"10.1021\/acsnano.9b05115","article-title":"Nanodelivery of mycophenolate mofetil to the organ improves transplant vasculopathy.","volume":"13","author":"Uehara","year":"2019","journal-title":"ACS Nano"},{"key":"R62-20250604","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1080\/10717544.2018.1447049","article-title":"On-target and direct modulation of alloreactive T cells by a nanoparticle carrying MHC alloantigen, regulatory molecules and CD47 in a murine model of alloskin transplantation.","volume":"25","author":"Shahzad","year":"2018","journal-title":"Drug Deliv"},{"key":"R63-20250604","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1111\/j.1600-6143.2011.03725.x","article-title":"Nanoparticle delivery of mycophenolic acid upregulates PD-L1 on dendritic cells to prolong murine allograft survival.","volume":"11","author":"Shirali","year":"2011","journal-title":"Am J Transplant"},{"key":"R64-20250604","doi-asserted-by":"crossref","first-page":"9794235","DOI":"10.34133\/2022\/9794235","article-title":"Helper T cell (CD4+) targeted tacrolimus delivery mediates precise suppression of allogeneic humoral immunity.","volume":"2022","author":"Shen","year":"2022","journal-title":"Research"},{"key":"R65-20250604","doi-asserted-by":"crossref","first-page":"6492","DOI":"10.1039\/D2BM02103J","article-title":"Targeted microRNA delivery by lipid nanoparticles and gas vesicle-assisted ultrasound cavitation to treat heart transplant rejection. 10.1039\/D2BM02103J.","volume":"11","author":"Wang","year":"2023","journal-title":"Biomater Sci"},{"key":"R66-20250604","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jconrel.2020.08.043","article-title":"Target-oriented delivery of self-assembled immunosuppressant cocktails prolongs allogeneic orthotopic liver transplant survival.","volume":"328","author":"Xie","year":"2020","journal-title":"J Controlled Release"},{"key":"R67-20250604","doi-asserted-by":"crossref","first-page":"7959","DOI":"10.1021\/acsnano.9b09065","article-title":"Engineering programmed death ligand-1\/cytotoxic T-lymphocyte-associated antigen-4 dual-targeting nanovesicles for immunosuppressive therapy in transplantation.","volume":"14","author":"Xu","year":"2020","journal-title":"ACS Nano"},{"key":"R68-20250604","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1039\/D0BM01798A","article-title":"PD-L1 cellular nanovesicles carrying rapamycin inhibit alloimmune responses in transplantation.","volume":"9","author":"Yang","year":"2021","journal-title":"Biomater Sci"},{"key":"R69-20250604","doi-asserted-by":"crossref","first-page":"120826","DOI":"10.1016\/j.biomaterials.2021.120826","article-title":"Microfluidic formulation of nanoparticles for biomedical applications.","volume":"274","author":"Shepherd","year":"2021","journal-title":"Biomaterials"},{"key":"R70-20250604","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1023\/B:PHAM.0000016234.73023.75","article-title":"Design of freeze-drying processes for pharmaceuticals: practical advice.","volume":"21","author":"Tang","year":"2004","journal-title":"Pharm Res"},{"key":"R71-20250604","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/s41551-021-00698-w","article-title":"The evolution of commercial drug delivery technologies.","volume":"5","author":"Vargason","year":"2021","journal-title":"Nat Biomed Eng"},{"key":"R72-20250604","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1038\/s41563-021-01047-7","article-title":"Obstacles and opportunities in a forward vision for cancer nanomedicine.","volume":"20","author":"de L\u00e1zaro","year":"2021","journal-title":"Nat Mater"},{"key":"R73-20250604","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41578-022-00529-7","article-title":"Passive, active and endogenous organ-targeted lipid and polymer nanoparticles for delivery of genetic drugs.","volume":"8","author":"Dilliard","year":"2023","journal-title":"Nat Rev Mater"},{"key":"R74-20250604","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2217\/nnm.16.5","article-title":"The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction.","volume":"11","author":"Hoshyar","year":"2016","journal-title":"Nanomedicine (Lond)"},{"key":"R75-20250604","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nnano.2007.70","article-title":"Shape effects of filaments versus spherical particles in flow and drug delivery.","volume":"2","author":"Geng","year":"2007","journal-title":"Nat Nanotechnol"},{"key":"R76-20250604","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jconrel.2022.03.043","article-title":"Strategies to improve the EPR effect: a mechanistic perspective and clinical translation.","volume":"345","author":"Ikeda-Imafuku","year":"2022","journal-title":"J Control Release"},{"key":"R77-20250604","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0022-4804(85)90107-6","article-title":"Changes in lung vascular permeability after heart-lung transplantation.","volume":"39","author":"Mancini","year":"1985","journal-title":"J Surg Res"},{"key":"R78-20250604","doi-asserted-by":"crossref","first-page":"8405370","DOI":"10.1155\/2020\/8405370","article-title":"Ischemia\/reperfusion injury: pathophysiology, current clinical management, and potential preventive approaches.","volume":"2020","author":"S\u00e1nchez-Hern\u00e1ndez","year":"2020","journal-title":"Mediators Inflamm"},{"key":"R79-20250604","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1038\/s41598-018-19621-6","article-title":"Generation and characterization of alloantigen-specific regulatory T cells for clinical transplant tolerance.","volume":"8","author":"Mathew","year":"2018","journal-title":"Sci Rep"},{"key":"R80-20250604","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/s41467-020-20886-7","article-title":"Surface chemistry-mediated modulation of adsorbed albumin folding state specifies nanocarrier clearance by distinct macrophage subsets.","volume":"12","author":"Vincent","year":"2021","journal-title":"Nat Commun"},{"key":"R81-20250604","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrd.2016.199","article-title":"Aptamers as targeted therapeutics: current potential and challenges.","volume":"16","author":"Zhou","year":"2017","journal-title":"Nat Rev Drug Discov"},{"key":"R82-20250604","doi-asserted-by":"crossref","first-page":"4770","DOI":"10.1172\/JCI120923","article-title":"Targeted delivery of immune therapeutics to lymph nodes prolongs cardiac allograft survival.","volume":"128","author":"Bahmani","year":"2018","journal-title":"J Clin Invest"},{"key":"R83-20250604","doi-asserted-by":"crossref","first-page":"2207227","DOI":"10.1002\/adma.202207227","article-title":"Lymph-node-targeted drug delivery for effective immunomodulation to prolong the long-term survival after heart transplantation.","volume":"35","author":"Che","year":"2023","journal-title":"Adv Mater"},{"key":"R84-20250604","doi-asserted-by":"crossref","first-page":"e2116271119","DOI":"10.1073\/pnas.2116271119","article-title":"Lung-selective mRNA delivery of synthetic lipid nanoparticles for the treatment of pulmonary lymphangioleiomyomatosis.","volume":"119","author":"Qiu","year":"2022","journal-title":"Proc Natl Acad Sci USA"},{"key":"R85-20250604","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/TP.0b013e31823cab44","article-title":"Mechanisms of rejection: current perspectives.","volume":"93","author":"Wood","year":"2012","journal-title":"Transplantation"},{"key":"R86-20250604","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1111\/ajt.15806","article-title":"Lymphatic vessels in solid organ transplantation and immunobiology.","volume":"20","author":"Wong","year":"2020","journal-title":"Am J Transplant"},{"key":"R87-20250604","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1097\/01.tp.0000209210.75211.57","article-title":"Vascularized lymph node transplantation induces graft-versus-host disease in chimeric hosts.","volume":"81","author":"Francois","year":"2006","journal-title":"Transplantation"},{"key":"R88-20250604","doi-asserted-by":"crossref","first-page":"e159672","DOI":"10.1172\/JCI159672","article-title":"Delivery of costimulatory blockade to lymph nodes promotes transplant acceptance in mice.","volume":"132","author":"Zhao","year":"2022","journal-title":"J Clin Invest"},{"key":"R89-20250604","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1016\/j.jtcvs.2017.07.083","article-title":"The efficacy of inhaled nanoparticle tacrolimus in preventing rejection in an orthotopic rat lung transplant model.","volume":"154","author":"Nitin Andrew Das","year":"2017","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R90-20250604","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.kint.2022.06.024","article-title":"Targeting inflammatory monocytes by immune-modifying nanoparticles prevents acute kidney allograft rejection.","volume":"102","author":"Lai","year":"2022","journal-title":"Kidney Int"},{"key":"R91-20250604","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1097\/TP.0000000000003060","article-title":"Liposomal delivery improves the efficacy of prednisolone to attenuate renal inflammation in a mouse model of acute renal allograft rejection.","volume":"104","author":"van Alem","year":"2020","journal-title":"Transplantation"},{"key":"R92-20250604","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/s41573-021-00242-0","article-title":"The glomerular filtration barrier: a structural target for novel kidney therapies.","volume":"20","author":"Daehn","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"R93-20250604","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jconrel.2021.04.016","article-title":"Improving kidney targeting: the influence of nanoparticle physicochemical properties on kidney interactions.","volume":"334","author":"Huang","year":"2021","journal-title":"J Control Release"},{"key":"R94-20250604","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41578-018-0038-3","article-title":"Transport and interactions of nanoparticles in the kidneys.","volume":"3","author":"Du","year":"2018","journal-title":"Nat Rev Mater"},{"key":"R95-20250604","doi-asserted-by":"crossref","first-page":"5584","DOI":"10.1007\/s12274-018-2100-2","article-title":"Design and in vivo characterization of kidney-targeting multimodal micelles for renal drug delivery.","volume":"11","author":"Wang","year":"2018","journal-title":"Nano Res"},{"key":"R96-20250604","doi-asserted-by":"crossref","first-page":"eaam6764","DOI":"10.1126\/scitranslmed.aam6764","article-title":"Nanoparticle targeting to the endothelium during normothermic machine perfusion of human kidneys.","volume":"9","author":"Tietjen","year":"2017","journal-title":"Sci Transl Med"},{"key":"R97-20250604","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nrgastro.2015.200","article-title":"Immunology in the liver\u2014from homeostasis to disease.","volume":"13","author":"Heymann","year":"2016","journal-title":"Nature Rev Gastroenterol Hepatol"},{"key":"R98-20250604","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/s41575-020-0334-4","article-title":"Understanding, predicting and achieving liver transplant tolerance: from bench to bedside.","volume":"17","author":"Thomson","year":"2020","journal-title":"Nature Rev Gastroenterol Hepatol"},{"key":"R99-20250604","doi-asserted-by":"crossref","first-page":"1604062","DOI":"10.1002\/adma.201604062","article-title":"Amino acids and peptide-based supramolecular hydrogels for three-dimensional cell culture.","volume":"29","author":"Dou","year":"2017","journal-title":"Adv Mater"},{"key":"R100-20250604","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/s41428-020-0333-x","article-title":"Enzyme responsive properties of amphiphilic urea supramolecular hydrogels.","volume":"52","author":"Maki","year":"2020","journal-title":"Polym J"},{"key":"R101-20250604","doi-asserted-by":"crossref","first-page":"1805018","DOI":"10.1002\/adma.201805018","article-title":"Immune responsive release of tacrolimus to overcome organ transplant rejection.","volume":"30","author":"Wu","year":"2018","journal-title":"Adv Mater"},{"key":"R102-20250604","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12951-022-01307-x","article-title":"A roadmap to pulmonary delivery strategies for the treatment of infectious lung diseases.","volume":"20","author":"He","year":"2022","journal-title":"J Nanobiotechnol"},{"key":"R103-20250604","doi-asserted-by":"crossref","first-page":"eabn7162","DOI":"10.1126\/sciadv.abn7162","article-title":"Inhaled siRNA nanoparticles targeting IL11 inhibit lung fibrosis and improve pulmonary function post-bleomycin challenge.","volume":"8","author":"Bai","year":"2022","journal-title":"Sci Adv"},{"key":"R104-20250604","doi-asserted-by":"crossref","first-page":"20726","DOI":"10.1038\/s41598-020-77828-y","article-title":"Loading imatinib inside targeted nanoparticles to prevent bronchiolitis obliterans syndrome.","volume":"10","author":"Pandolfi","year":"2020","journal-title":"Sci Rep"},{"key":"R105-20250604","doi-asserted-by":"crossref","first-page":"120366","DOI":"10.1016\/j.biomaterials.2020.120366","article-title":"Targeted galectin-7 inhibition with ultrasound microbubble targeted gene therapy as a sole therapy to prevent acute rejection following heart transplantation in a rodent model.","volume":"263","author":"Wang","year":"2020","journal-title":"Biomaterials"},{"key":"R106-20250604","doi-asserted-by":"crossref","first-page":"3729","DOI":"10.1039\/C9BM00301K","article-title":"Improving acute cardiac transplantation rejection therapy using ultrasound-targeted FK506-loaded microbubbles in rats.","volume":"7","author":"Liu","year":"2019","journal-title":"Biomater Sci"},{"key":"R107-20250604","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.biomaterials.2018.02.017","article-title":"Ultrasound molecular imaging of acute cardiac transplantation rejection using nanobubbles targeted to T lymphocytes.","volume":"162","author":"Liu","year":"2018","journal-title":"Biomaterials"},{"key":"R108-20250604","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1038\/s41598-020-57943-6","article-title":"Understanding the lipid and protein corona formation on different sized polymeric nanoparticles.","volume":"10","author":"Lima","year":"2020","journal-title":"Sci Rep"},{"key":"R109-20250604","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/s41392-023-01377-9","article-title":"Activation of immune signals during organ transplantation.","volume":"8","author":"Li","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"R110-20250604","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1586\/14737159.2013.819216","article-title":"Monocytes and macrophages as nanomedicinal targets for improved diagnosis and treatment of disease.","volume":"13","author":"Lameijer","year":"2013","journal-title":"Expert Rev Mol Diagn"},{"key":"R111-20250604","doi-asserted-by":"crossref","first-page":"eabq3699","DOI":"10.1126\/sciadv.abq3699","article-title":"Nanoparticle delivery of CD40 siRNA suppresses alloimmune responses by inhibiting activation and differentiation of DCs and macrophages.","volume":"8","author":"Wang","year":"2022","journal-title":"Sci Adv"},{"key":"R112-20250604","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nnano.2017.57","article-title":"In situ programming of leukaemia-specific T cells using synthetic DNA nanocarriers.","volume":"12","author":"Smith","year":"2017","journal-title":"Nat Nanotechnol"},{"key":"R113-20250604","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1126\/science.abm0594","article-title":"CAR T cells produced in vivo to treat cardiac injury.","volume":"375","author":"Rurik","year":"2022","journal-title":"Science"},{"key":"R114-20250604","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1161\/CIRCRESAHA.115.306565","article-title":"Cardiac fibrosis: the fibroblast awakens.","volume":"118","author":"Travers","year":"2016","journal-title":"Circ Res"},{"key":"R115-20250604","doi-asserted-by":"crossref","first-page":"e157262","DOI":"10.1172\/JCI157262","article-title":"CD11b suppresses TLR activation of nonclassical monocytes to reduce primary graft dysfunction after lung transplantation.","volume":"132","author":"Querrey","year":"2022","journal-title":"J Clin Invest"},{"key":"R116-20250604","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.immuni.2018.09.008","article-title":"Inhibiting inflammation with myeloid cell-specific nanobiologics promotes organ transplant acceptance.","volume":"49","author":"Braza","year":"2018","journal-title":"Immunity"},{"key":"R117-20250604","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/nri2132","article-title":"Tolerogenic dendritic cells and the quest for transplant tolerance.","volume":"7","author":"Morelli","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"R118-20250604","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nri3212","article-title":"Advances in graft-versus-host disease biology and therapy.","volume":"12","author":"Blazar","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"R119-20250604","doi-asserted-by":"crossref","first-page":"6637","DOI":"10.1021\/acsnano.8b01625","article-title":"Murine and non-human primate dendritic cell targeting nanoparticles for in vivo generation of regulatory T-cells.","volume":"12","author":"Stead","year":"2018","journal-title":"ACS Nano"},{"key":"R120-20250604","doi-asserted-by":"crossref","first-page":"104624","DOI":"10.1016\/j.ebiom.2023.104624","article-title":"Nanotherapeutics for solid organ transplantation: new kid on the block.","volume":"92","author":"Xu","year":"2023","journal-title":"EBioMedicine"},{"key":"R121-20250604","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1021\/acsmeasuresciau.2c00003","article-title":"Understanding the significance of sample preparation in studies of the nanoparticle metabolite corona.","volume":"2","author":"Zhang","year":"2022","journal-title":"ACS Meas Sci Au"},{"key":"R122-20250604","doi-asserted-by":"crossref","first-page":"11773","DOI":"10.1021\/acsnano.7b08008","article-title":"A decade of the protein corona.","volume":"11","author":"Ke","year":"2017","journal-title":"ACS Nano"},{"key":"R123-20250604","doi-asserted-by":"crossref","first-page":"16014","DOI":"10.1038\/natrevmats.2016.14","article-title":"Analysis of nanoparticle delivery to tumours.","volume":"1","author":"Wilhelm","year":"2016","journal-title":"Nat Rev Mater"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000005025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T18:00:55Z","timestamp":1749060055000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000005025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,8]]},"references-count":123,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000005025","relation":{},"ISSN":["0041-1337","1534-6080"],"issn-type":[{"value":"0041-1337","type":"print"},{"value":"1534-6080","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,8]]}}}